Top compounds associated with response to DGKH


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.055 0.07
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC -0.092 0.07
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.072 0.07
mRNA Erlotinib CCLE pan-cancer AAC 0.084 0.07
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.08
mRNA Bleomycin CTRPv2 pan-cancer AAC 0.068 0.08
mRNA GSK525762A CTRPv2 pan-cancer AAC 0.054 0.08
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.066 0.08
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.056 0.08
Download CSV